Decatur Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55M Buy
11,569
+12
+0.1% +$3.32K 0.87% 31
2026
Q1
$3.41M Sell
11,557
-185
-2% -$55K 1.56% 20
2025
Q4
$3.21M Sell
11,742
-617
-5% -$168K 1.3% 21
2025
Q3
$3.34M Buy
12,359
+43
+0.3% +$11.7K 1.33% 23
2025
Q2
$3.39M Buy
12,316
+43
+0.4% +$11.7K 1.49% 20
2025
Q1
$3.26M Buy
+12,273
New +$3.03M 1.69% 18

Other funds holding CME

Decatur Capital Management's CME Position: Q2 2026 in Review

Decatur Capital Management increased its CME Group (CME) stake by 0.1% in Q2 2026, buying an estimated $3.32K and bringing the position to 11,569 shares worth $2.55M. The position accounts for 0.87% of the portfolio, ranked #31.

Decatur Capital Management first reported a position in CME in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.41M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Decatur Capital Management held 11,569 shares of CME Group worth $2.55M as of Q2 2026.
  • Decatur Capital Management bought 12 CME Group shares in Q2 2026, an estimated $3.32K.
  • CME Group made up 0.87% of Decatur Capital Management's portfolio in Q2 2026, its #31 holding.
  • Decatur Capital Management first reported a position in CME Group in Q1 2025 and has held it in 6 quarters since.
  • Decatur Capital Management's CME Group position peaked at $3.41M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Decatur Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.